PropThink: What Vivus’ and Arena’s Earnings Mean for Orexigen

[ACN Newswire] – By Jake KingOrexigen Therapeutics (NASDAQ:OREX) will be releasing its third quarter earnings report after the market’s close Wednesday night, and with all of the hoopla surrounding obesity drugs Qsymia … more

View todays social media effects on ARNA

View the latest stocks trending across Twitter. Click to view dashboard